Learn about LEQVIO results and safetyActor portrayal.
LDL-C, low-density lipoprotein cholesterol.
LEQVIO is proven to lower bad cholesterol (LDL-C) by 50% and helps keep it low.
At month 17, LEQVIO lowered bad cholesterol and kept it lower with 2 doses a year compared to statins alone.
*LEQVIO lowered bad cholesterol more during each 6-month dosing interval than placebo (a substance without medication).
Individual results may vary.
Laura S.
LEQVIO patient compensated for her time.
Individual results may vary.
"It's nice to be able to take something only twice a year."
Get inspired by real patients who have treated their bad cholesterol (LDL-C) with LEQVIO.
Talk to your doctor about LEQVIO today
If your doctor prescribes LEQVIO, you may pay as little as $0†‡
Sign up for savings and supportGet tips, resources, and tools
Sign up to receive emails with more information on lowering bad cholesterol. Plus, you'll get tools to help you along your journey to lower bad cholesterol.
Only LEQVIO lowers bad cholesterol with 2 doses a year, after 2 initial doses.
Adults who added LEQVIO to a statin lowered bad cholesterol more and kept it lower with 2 doses a year compared to statins alone. Individual results may vary.
†Terms & Conditions apply.
‡Data on file. LEQVIO Coverage and Affordability. Novartis Pharmaceuticals Corp; 2024.
Definitions: ASCVD, atherosclerotic cardiovascular disease; LDL-C, low-density lipoprotein cholesterol.